id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0582-0132,FDA,FDA-2009-N-0582,TAB A-2016-994-Direct to Consumer-Final  Rule-Original,Supporting & Related Material,Background Material,2024-01-05T05:00:00Z,2024,1,,,2024-01-05T13:40:49Z,,0,0,0900006486375b66
FDA-2009-N-0582-0131,FDA,FDA-2009-N-0582,Direct to Consumer Memorandum,Supporting & Related Material,Memorandum,2024-01-05T05:00:00Z,2024,1,,,2024-01-05T13:40:49Z,,0,0,0900006486375b65
FDA-2009-N-0582-0135,FDA,FDA-2009-N-0582,TAB B-2016-994-Direct to Consumer-FRIA-TRACK CHANGE FROM ORIGINAL TO FINAL,Supporting & Related Material,Background Material,2024-01-05T05:00:00Z,2024,1,,,2024-01-05T13:40:51Z,,0,0,0900006486375b69
FDA-2009-N-0582-0134,FDA,FDA-2009-N-0582,TAB B-2016-994-Direct to Consumer-Final Rule-TRACK CHANGE FROM ORIGINAL TO FINAL,Supporting & Related Material,Background Material,2024-01-05T05:00:00Z,2024,1,,,2024-01-05T13:40:50Z,,0,0,0900006486375b68
FDA-2009-N-0582-0136,FDA,FDA-2009-N-0582,TAB C-2016-994-Direct to Consumer FRIA-Final,Supporting & Related Material,Background Material,2024-01-05T05:00:00Z,2024,1,,,2024-01-05T13:40:52Z,,0,0,0900006486375b6a
FDA-2009-N-0582-0133,FDA,FDA-2009-N-0582,TAB-A-2016-994-Direct to Consumer-FRIA-Orginal,Supporting & Related Material,Background Material,2024-01-05T05:00:00Z,2024,1,,,2024-01-05T13:40:50Z,,0,0,0900006486375b67
FDA-2009-N-0582-0137,FDA,FDA-2009-N-0582,TAB C-2016-994-Direct to Consumer-Final Rule-Final,Supporting & Related Material,Background Material,2024-01-05T05:00:00Z,2024,1,,,2024-01-05T13:40:52Z,,0,0,0900006486375b6b
FDA-2009-N-0582-0130,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear,
Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format Final Rule: Questions and Answers; Guidance for Industry; Small Entity Compliance Guide; Availability",Rule,Final Rule with Request for Comments,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-27T14:34:36Z,2023-28530,0,0,090000648635c371
FDA-2009-N-0582-0129,FDA,FDA-2009-N-0582,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:23:07Z,2023-28290,0,0,0900006486351614
FDA-2009-N-0582-0061,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Rule,Direct Final Rule,2023-11-21T05:00:00Z,2023,11,2023-11-21T05:00:00Z,,2024-01-05T14:03:16Z,2023-25428,0,0,090000648629f6eb
FDA-2009-N-0582-0070,FDA,FDA-2009-N-0582,"08 Reference 8 How DTC Spending Shifted in 2020_Medical Marketing and Media_2021 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:16:07Z,,0,0,090000648629f8c1
FDA-2009-N-0582-0090,FDA,FDA-2009-N-0582,"28 Reference 28 Capacity Limits in Selective Attention Behavioral Evidence and Implications for Neural Activity_Lavie_2001 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:31:22Z,,0,0,09000064862a052d
FDA-2009-N-0582-0092,FDA,FDA-2009-N-0582,"30 Reference 30 Temporal Methods for Studying Attention How Did We Get Here and Where Are We Going_Shapiro_2001 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:32:32Z,,0,0,09000064862a052f
FDA-2009-N-0582-0115,FDA,FDA-2009-N-0582,"53 Reference 53 The Implications of the FTC's Clear and Conspicuous Standards for the Communication of Credit Card Information to Young Consumers_Thomas_2011 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:42:50Z,,0,0,09000064862a0679
FDA-2009-N-0582-0105,FDA,FDA-2009-N-0582,"43 Reference 43 Aging and Direct-to-Consumer Prescription Drug Television Ads The Effects of Individual Differences and Risk Presentation_O'Donoghue_2019 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:40:54Z,,0,0,09000064862a058f
FDA-2009-N-0582-0112,FDA,FDA-2009-N-0582,"50 Reference 50 H. Rept. No.102-839_1992 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:42:11Z,,0,0,09000064862a05d8
FDA-2009-N-0582-0103,FDA,FDA-2009-N-0582,41 Reference 41 Age Affective Experience and Television Use_Depp_2010,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:40:41Z,,0,0,09000064862a05da
FDA-2009-N-0582-0118,FDA,FDA-2009-N-0582,"56 Reference 56 Effect of Presentation Modality in Direct-to-Consumer (DTC) Prescription Drug Television Advertisements_Wogalter_2014 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:43:24Z,,0,0,09000064862a06c3
FDA-2009-N-0582-0062,FDA,FDA-2009-N-0582,00 References List CCN Final Rule 10-24-23,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:11:41Z,,0,0,090000648629f897
FDA-2009-N-0582-0064,FDA,FDA-2009-N-0582,"02 Reference 2 Direct-to-Consumer Advertising of Prescription Drugs and the Patient Prescriber Encounter A Systematic Review_DeFrank_2020 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:12:03Z,,0,0,090000648629f899
FDA-2009-N-0582-0076,FDA,FDA-2009-N-0582,"14 Reference 14 Factors Influencing Consumers' Attitudinal and Behavioral Responses to Direct-to-Consumer and Over-the-Counter Drug Advertising_Lee_2015 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:17:49Z,,0,0,090000648629f8c7
FDA-2009-N-0582-0086,FDA,FDA-2009-N-0582,"24 Reference 24 An Integrated Career Coaching and Time-Banking System Promoting FlexibilityWellness  and Success A Pilot Program at Stanford University School of Medicine_Fassiotto_2018 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:20:34Z,,0,0,09000064862a0528
FDA-2009-N-0582-0088,FDA,FDA-2009-N-0582,"26 Reference 26 Draft Guidance for Industry Presenting Risk Information in Prescription Drug and Medical Device Promotion_FDA_2009 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:20:50Z,,0,0,09000064862a052a
FDA-2009-N-0582-0097,FDA,FDA-2009-N-0582,"35 Reference 35 Music is as Distracting as Noise The Differential Distraction of Background Music and Noise on the Cognitive Test Performance of Introverts and Extraverts_Furnham_2002 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:39:39Z,,0,0,09000064862a058b
FDA-2009-N-0582-0100,FDA,FDA-2009-N-0582,"38 Reference 38 Sources of Miscomprehension in Television Advertising_Hoyer_1984 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:39:57Z,,0,0,09000064862a058e
FDA-2009-N-0582-0108,FDA,FDA-2009-N-0582,46 Reference 46 Provision of Effective Information_Baker_2006,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:41:44Z,,0,0,09000064862a05dc
FDA-2009-N-0582-0091,FDA,FDA-2009-N-0582,"29 Reference 29 The Magical Number Seven Plus or Minus Two Some Limits on Our Capacity for Processing Information_Miller_1956 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:32:20Z,,0,0,09000064862a052e
FDA-2009-N-0582-0099,FDA,FDA-2009-N-0582,"37 Reference 37 Distraction and Attitude Change A Resolution_Regan_1973 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:39:51Z,,0,0,09000064862a058d
FDA-2009-N-0582-0110,FDA,FDA-2009-N-0582,"48 Reference 48 Quantifying Perceived Differences in Type Styles An Exploratory Study_Tantillo_1995 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:41:58Z,,0,0,09000064862a0591
FDA-2009-N-0582-0079,FDA,FDA-2009-N-0582,"17 Reference 17 Consumers Reports on the Health Effects of Direct-to-Consumer Drug AdvertisingWeissman2003 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:18:38Z,,0,0,090000648629f8f6
FDA-2009-N-0582-0083,FDA,FDA-2009-N-0582,"21 Reference 21 Time Allocation in Primary Care Office Visits_Tai-Seale_2007 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:19:39Z,,0,0,090000648629f8fa
FDA-2009-N-0582-0116,FDA,FDA-2009-N-0582,"54 Reference 54 An Empirical Examination of the FDAAA-Mandated Toll-Free Statement for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements_Aikin_2016 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:43:00Z,,0,0,09000064862a06ad
FDA-2009-N-0582-0109,FDA,FDA-2009-N-0582,47 Reference 47 Text Legibility and the Letter Superiority Effect_Sheedy_2005,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:41:50Z,,0,0,09000064862a05de
FDA-2009-N-0582-0125,FDA,FDA-2009-N-0582,"63 Reference 63 Defining Audio-Video Redundancy From a Limited-Capacity Information Processing Perspective_Lang_1995 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:44:22Z,,0,0,09000064862a067a
FDA-2009-N-0582-0120,FDA,FDA-2009-N-0582,"58 Reference 58 The Empirical Case for Dual Coding_Paivio_1983 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:43:43Z,,0,0,09000064862a067b
FDA-2009-N-0582-0074,FDA,FDA-2009-N-0582,"12 Reference 12 Kaiser Health Tracking Poll October 2015_DiJulio_2015 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:17:32Z,,0,0,090000648629f8c5
FDA-2009-N-0582-0080,FDA,FDA-2009-N-0582,"18 Reference 18 Fair Balance in Direct-to-Consumer Antidepressant Print and Television Advertising_Avery_2012 
RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:18:51Z,,0,0,090000648629f8f7
FDA-2009-N-0582-0089,FDA,FDA-2009-N-0582,"27 Reference 27 Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information Technical Research Report_FDA_2011RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:21:06Z,,0,0,09000064862a052b
FDA-2009-N-0582-0075,FDA,FDA-2009-N-0582,"13 Reference 13 2017 Direct-to-Consumer Advertising Survey Results_Princeton Survey Research Associates for PhRMA_2017 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:17:38Z,,0,0,090000648629f8c6
FDA-2009-N-0582-0065,FDA,FDA-2009-N-0582,"03 Reference 3 Promotion of Prescription Drugs to Consumers and Providers 20012010_Kornfield_2013 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:12:12Z,,0,0,09000064862a084c
FDA-2009-N-0582-0093,FDA,FDA-2009-N-0582,"31 Reference 31 Factors That Guide or Disrupt Attentive Visual Processing_Hillstrom_2006 
RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:32:38Z,,0,0,09000064862a0530
FDA-2009-N-0582-0101,FDA,FDA-2009-N-0582,"39 Reference 39 The Effect of Background Music and Background Noise on the Task Performance of Introverts and Extraverts_Cassidy_2007 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:40:21Z,,0,0,09000064862a0590
FDA-2009-N-0582-0106,FDA,FDA-2009-N-0582,"44 Reference 44 Quantifying and Predicting the Effects of Basic Text Display Variables on the Perceived Urgency of Warning Labels_Adams_1995 

RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:41:18Z,,0,0,09000064862a05d5
FDA-2009-N-0582-0113,FDA,FDA-2009-N-0582,51 Reference 51 The Self-Confidence Advertising Response Relationship A Function of Situational Disctraction_Bither_1973,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:42:23Z,,0,0,09000064862a0614
FDA-2009-N-0582-0127,FDA,FDA-2009-N-0582,"65 Reference 65 Commission Enforcement Policy Statement in Regard to Clear and Conspicuous Disclosure in Television Advertising_FTC_1970 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:44:39Z,,0,0,09000064862a067f
FDA-2009-N-0582-0096,FDA,FDA-2009-N-0582,"34 Reference 34 Comprehension of Info-Aid Supers in Television Advertising for Social Ideas Implications for Public Policy_Manrai_1994 
RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:32:58Z,,0,0,09000064862a058a
FDA-2009-N-0582-0123,FDA,FDA-2009-N-0582,"61 Reference 61 What Effect Do Mixed Sensory Mode Instructional Formats Have on Both Novice and Experienced Learners of Chinese Characters_Chung_2008 RE:Direct-to-Consumer Prescription Drug  Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:44:03Z,,0,0,09000064862a06c5
FDA-2009-N-0582-0082,FDA,FDA-2009-N-0582,"20 Reference 20 Patients Willing to Wait Arrival Time Wait Time and Patient Satisfaction in an Ambulatory Urology Clinic_Donahue_2017 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:19:10Z,,0,0,090000648629f8f9
FDA-2009-N-0582-0084,FDA,FDA-2009-N-0582,"22 Reference 22 A Time Motion Study of Primary Care Physicians' Work in the Electronic Health Record Era_Young_2018 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:20:14Z,,0,0,090000648629f8fb
FDA-2009-N-0582-0063,FDA,FDA-2009-N-0582,"01 Reference 1 Guidance for Industry Consumer-Directed Broadcast Advertisements_FDA_1999 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:11:52Z,,0,0,090000648629f898
FDA-2009-N-0582-0066,FDA,FDA-2009-N-0582,"04 Reference 4 Trends in Exposure to Televised Prescription Drug Advertising 20032011Kornfield2015 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:15:07Z,,0,0,090000648629f89a
FDA-2009-N-0582-0121,FDA,FDA-2009-N-0582,"59 Reference 59 The Effects of Audio-Visual and Visual-Only Cues on Consumers Responses to Co-Branded Advertising_Wang_2010 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:43:49Z,,0,0,09000064862a06ae
FDA-2009-N-0582-0072,FDA,FDA-2009-N-0582,"10 Reference 10 An Updated Analysis of DTC TV Advertisements for Prescription Drugs_Applequist_2018 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:16:58Z,,0,0,090000648629f8c3
FDA-2009-N-0582-0077,FDA,FDA-2009-N-0582,"15 Reference 15 Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs Summary of FDA Survey Research Results_Aikin_2004 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:17:59Z,,0,0,090000648629f8f4
FDA-2009-N-0582-0111,FDA,FDA-2009-N-0582,"49 Reference 49 Effects of Label Format on Knowledge Acquisition and Perceived Readability by Younger and Older Adults_Wogalter_2003 
RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:42:05Z,,0,0,09000064862a05d6
FDA-2009-N-0582-0128,FDA,FDA-2009-N-0582,"66 Reference 66 Economic Analysis of Impacts Direct-to-Consumer Prescription Drug Advertisements_FDA_2023 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:44:49Z,,0,0,09000064862a06b2
FDA-2009-N-0582-0104,FDA,FDA-2009-N-0582,42 Reference 42 Prescription Drug Use Continues to Increase U.S. Prescription Drug Data for 20072008 NCHS Data Brief_Gu_2010,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:40:47Z,,0,0,09000064862a05dd
FDA-2009-N-0582-0119,FDA,FDA-2009-N-0582,"57 Reference 57 Cognitive Psychology In and Out of the Laboratory_Galotti_2004 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:43:38Z,,0,0,09000064862a0676
FDA-2009-N-0582-0117,FDA,FDA-2009-N-0582,55 Reference 55 Attention to and Distraction from Risk Information in Prescription Drug Advertising An Eye Tracking Study_Sullivan_2017,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:43:07Z,,0,0,09000064862a06c0
FDA-2009-N-0582-0094,FDA,FDA-2009-N-0582,"32 Reference 32 Distraction Can Enhance or Reduce Yielding to Propaganda Thought Disruption Versus Effort Justification_Petty_1976 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:32:43Z,,0,0,09000064862a0588
FDA-2009-N-0582-0095,FDA,FDA-2009-N-0582,"33 Reference 33 Modifying the Impact of Persuasive Communications with External Distraction_Zimbardo_1970 
RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:32:48Z,,0,0,09000064862a0589
FDA-2009-N-0582-0102,FDA,FDA-2009-N-0582,"40 Reference 40 Clear and Conspicuous Disclosure_CCH Trade Regulation Reporter_1970 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:40:31Z,,0,0,09000064862a05d7
FDA-2009-N-0582-0107,FDA,FDA-2009-N-0582,45 Reference 45 Serifs and Font Legibility_Arditi_2005,Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:41:35Z,,0,0,09000064862a05d9
FDA-2009-N-0582-0126,FDA,FDA-2009-N-0582,"64 Reference 64 Recall of Television Versus Print News Retesting the Semantic Overlap Hypothesis_Walma_2004 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:44:32Z,,0,0,09000064862a067c
FDA-2009-N-0582-0068,FDA,FDA-2009-N-0582,"06 Reference 6 Trends in Urological Direct-to-Consumer Advertising during Prime-Time Television News Programs_Koo_2017 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:15:23Z,,0,0,090000648629f8bf
FDA-2009-N-0582-0073,FDA,FDA-2009-N-0582,"11 Reference 11 PhRMA Guiding Principles Direct to Consumer Advertisements About Prescription Medicines_PhRMA_2008 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:17:18Z,,0,0,090000648629f8c4
FDA-2009-N-0582-0069,FDA,FDA-2009-N-0582,"07 Reference 7 US Congressional Research Service_Direct-to-Consumer Advertising of Prescription Drugs Report_2009 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:15:34Z,,0,0,090000648629f8c0
FDA-2009-N-0582-0078,FDA,FDA-2009-N-0582,"16 Reference 16 Scientific Literature on Direct-to-Consumer Advertising of Prescription Pharmaceuticals 20042008 Literature ReviewEastern Research Group2009 
RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:18:08Z,,0,0,090000648629f8f5
FDA-2009-N-0582-0071,FDA,FDA-2009-N-0582,"09 Reference 9 The Top 10 Ad Spenders in Big Pharma for 2020_Fierce Pharma_Bulik 2021 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:16:16Z,,0,0,090000648629f8c2
FDA-2009-N-0582-0081,FDA,FDA-2009-N-0582,"19 Reference 19 Communicating Uncertainties About Prescription Drugs to the Public A National Randomized Trial_Schwartz_2011 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:18:59Z,,0,0,090000648629f8f8
FDA-2009-N-0582-0085,FDA,FDA-2009-N-0582,"23 Reference 23 Direct-to-Consumer Advertising Physicians' Views of Its Effects on Quality of Care and the Doctor-Patient Relationship_Murray_2003 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:20:26Z,,0,0,09000064862a0527
FDA-2009-N-0582-0087,FDA,FDA-2009-N-0582,"25 Reference 25 Allocation of Physician Time in Ambulatory Practice A Time and Motion Study in 4 Specialties_Sinsky_2016 
RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:20:43Z,,0,0,09000064862a0529
FDA-2009-N-0582-0124,FDA,FDA-2009-N-0582,"62 Reference 62 Using Both an Auditory and a Visual Short-Term Store to Increase Digit Span_Frick_1984 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:44:17Z,,0,0,09000064862a061d
FDA-2009-N-0582-0114,FDA,FDA-2009-N-0582,"52 Reference 52 Music to Your Brain Background Music Changes Are Processed First Reducing Ad Message Recall_Fraser_2013 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:42:40Z,,0,0,09000064862a061b
FDA-2009-N-0582-0098,FDA,FDA-2009-N-0582,"36 Reference 36 Processing Deficits and the Mediation of Positive Affect in Persuasion_Mackie_1989 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:39:46Z,,0,0,09000064862a058c
FDA-2009-N-0582-0122,FDA,FDA-2009-N-0582,"60 Reference 60 Improving Comprehension of Jury Instructions with Audio-Visual Presentation_Brewer_2004 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:43:59Z,,0,0,09000064862a06c2
FDA-2009-N-0582-0067,FDA,FDA-2009-N-0582,"05 Reference 5 Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects Results From the Health Information National Trends Survey Fourth_Sullivan_2015 RE:Direct-to-Consumer Prescription Drug Advertisements: Presentation of the
Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format",Supporting & Related Material,Background Material,2023-11-21T05:00:00Z,2023,11,,,2023-11-21T22:15:15Z,,0,0,090000648629f89b
FDA-2009-N-0582-0055,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner; Reopening of the Comment Period",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-03-23T04:00:00Z,2012,3,2012-03-23T04:00:00Z,2012-04-10T03:59:59Z,2023-10-25T16:01:08Z,2012-06948,0,0,0900006480fdf3d2
FDA-2009-N-0582-0040,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner; Notice of Availability of Study Data",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-01-27T05:00:00Z,2012,1,2012-01-27T05:00:00Z,2012-02-28T04:59:59Z,2023-10-25T16:02:27Z,2012-01672,0,0,0900006480fa7047
FDA-2009-N-0582-0017,FDA,FDA-2009-N-0582,"OMB Changes, Executive Order 12866 (E.O.)[Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner ] - Reference",Other,REF-Reference Material (internal attachments),2010-04-27T04:00:00Z,2010,4,2010-04-27T04:00:00Z,,2013-08-11T01:34:04Z,,0,0,0900006480ae15c4
FDA-2009-N-0582-0007,FDA,FDA-2009-N-0582,"Reference 12 - ""IMS Health, Total U.S. Promotional Spend By Type, 2008"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:20:19Z,,0,0,0900006480ac9fd4
FDA-2009-N-0582-0008,FDA,FDA-2009-N-0582,"Reference 13 - ""IMS Health, Integrated Promotional Services™, Year 2008, Data Extracted on September 2009"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:20:40Z,,0,0,0900006480ac9fd9
FDA-2009-N-0582-0009,FDA,FDA-2009-N-0582,"Reference 15 - ""Office of Management and Budget, Circular A-4, Setember 17, 2003"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:21:01Z,,0,0,0900006480ac9ffb
FDA-2009-N-0582-0013,FDA,FDA-2009-N-0582,"Reference 19 - ""Scientific Literature on Direct to Consumer Advertising of Precription Pharmaceuticals, 2004-2008; Eastern Research Group, Inc., Literature Review"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:22:43Z,,0,0,0900006480aca060
FDA-2009-N-0582-0003,FDA,FDA-2009-N-0582,"Reference 1 - ""FDA Guidance for Industry, ""Consumer-Directed Broadcast Advertisements,"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:18:52Z,,0,0,0900006480ac9f70
FDA-2009-N-0582-0002,FDA,FDA-2009-N-0582,DDMAC References -  [Note for MONDAY 3/29/2010 - POST THIS DOCUMENT FIRST BUT AFTER THE FR DOCUMENT AND Please Insert the Title of the FR Notice Here],Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:18:23Z,,0,0,0900006480aca149
FDA-2009-N-0582-0001,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner",Proposed Rule,NPR-Notice of Proposed Rule-Making,2010-03-29T04:00:00Z,2010,3,2010-03-29T04:00:00Z,2010-06-29T03:59:59Z,2012-11-30T03:02:04Z,2010-06996,0,0,0900006480aca825
FDA-2009-N-0582-0010,FDA,FDA-2009-N-0582,"Reference 16 - ""Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising Has Limitations, GAO"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:21:25Z,,0,0,0900006480aca03c
FDA-2009-N-0582-0006,FDA,FDA-2009-N-0582,"Reference 4 - ""FDA Draft Guidance for Industry, ""Presenting Risk Information in Prescription Drug and Medical Device Promotion,"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:19:59Z,,0,0,0900006480ac9f89
FDA-2009-N-0582-0004,FDA,FDA-2009-N-0582,"Reference 2 - ""CCH Trade Regulation Reporter, Paragraph 7569.09 ""Clear and Conspicous Disclosure,"" Ocober 21, 1970 - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:19:13Z,,0,0,0900006480ac9f86
FDA-2009-N-0582-0011,FDA,FDA-2009-N-0582,"Reference 17 - ""PhRMA Guiding Priniciples; Direct to Consumer Advertisements About Prescription Medicines, Revised December 2008"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:21:45Z,,0,0,0900006480aca040
FDA-2009-N-0582-0012,FDA,FDA-2009-N-0582,"Reference 18 - ""Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs--Summary of FDA Survey Research Results, Final Report, November 19, 2004"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:22:06Z,,0,0,0900006480aca044
FDA-2009-N-0582-0005,FDA,FDA-2009-N-0582,"Reference 3 - ""See H. Rept. No. 102-839, August 11, 1992"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:19:36Z,,0,0,0900006480ac9f87